O Brien Greene & Co. Inc Has $1.54 Million Stake in The Joint Corp. (NASDAQ:JYNT)

O Brien Greene & Co. Inc grew its stake in The Joint Corp. (NASDAQ:JYNT) by 20.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 144,620 shares of the company’s stock after purchasing an additional 25,000 shares during the period. O Brien Greene & Co. Inc owned about 0.97% of Joint worth $1,537,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in JYNT. FMR LLC increased its holdings in Joint by 38.0% in the 3rd quarter. FMR LLC now owns 10,787 shares of the company’s stock worth $123,000 after purchasing an additional 2,971 shares in the last quarter. Franklin Resources Inc. acquired a new position in shares of Joint in the third quarter valued at approximately $175,000. Sanders Morris Harris LLC bought a new position in Joint in the 4th quarter valued at approximately $228,000. BNP Paribas Financial Markets boosted its position in Joint by 5.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock worth $258,000 after buying an additional 1,156 shares during the period. Finally, Barclays PLC grew its holdings in Joint by 71.4% during the 3rd quarter. Barclays PLC now owns 25,609 shares of the company’s stock worth $294,000 after acquiring an additional 10,671 shares during the last quarter. 76.88% of the stock is owned by institutional investors.

Joint Stock Performance

Shares of NASDAQ JYNT opened at $11.45 on Thursday. The Joint Corp. has a 52-week low of $9.10 and a 52-week high of $17.82. The company’s 50 day moving average price is $10.87 and its 200-day moving average price is $11.21.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on JYNT. Roth Mkm dropped their price target on shares of Joint from $16.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, November 8th. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Friday, November 15th.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.